Wave Life Sciences Ltd (WVE NASDAQ) stock market data APIs
$3.1581
0.08(2.5%)
as of October 16, 2026
Try our APIs with
free plan!
Wave Life Sciences Ltd Financial Data Overview
Price chart is built with
Anychart
Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscular dystrophy and Huntington's disease, as well as various preclinical programs utilizing its RNA medicines platform. Wave Life Sciences, Inc. was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Prev. Close
3.1581
Open
3.2408
High
3.2888
Low
3.0531
52 wk Range
3.0399-21.73
Market Cap
617 M
Shares Outstanding
197 M
Revenue
65 371 K
EPS
-0.34
Beta
-1.428
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Wave Life Sciences Ltd (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Wave Life Sciences Ltd data using free add-ons & libraries
Get Wave Life Sciences Ltd Fundamental Data
Wave Life Sciences Ltd Fundamental data includes:
- Net Revenue: 65 371 K
- EBITDA: -214 520 000
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-07-30
- EPS/Forecast: -0.31
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Wave Life Sciences Ltd News
New
GSK (LSE:GSK) Following Its ADS Filing And The Case For Undervaluation
GSK (LSE:GSK) has put fresh capital plans on the table, filing a US shelf registration for up to $3.0498b of American Depositary Shares tied to its employee share ownership plans. GSK shares trade at...
Alnylam Pharmaceuticals (ALNY) vs. IONS and ARWR: Can Pipeline Growth Restore Confidence After the Guidance Cut?
Is ALNY a good stock to buy? We came across a bullish thesis on Alnylam Pharmaceuticals, Inc. on Astute Optics - US's Substack. The thesis was published on September 11th, when the stock was trading a...
GSK (LSE:GSK) Deepens Its Drug Pipeline Through Two Research Partnerships
GSK (LSE:GSK) has entered a collaboration with Wave Life Sciences to advance a GalNAc-siRNA hepatology candidate into its development pipeline. The partnership with Wave Life Sciences focuses on RNA-b...
4 RNA Therapeutics Stocks Leading the Next Wave of Innovation
RNA therapeutics are medicines that use RNA molecules to influence gene expression or protein production. Unlike many conventional drugs that act directly on proteins, RNA medicines can intervene earl...
Get Wave Life Sciences Ltd fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.